Solventum (SOLV)

• Market cap: $13.2B
• 1 day: 0.08%
• 5 days: 1.93%
• 1 month: -5.06%
• 3 months: 15.43%
• 6 months: 13.08%
• Year to date: 15.43%
• 1 year: 10.13%
• 5 years: 10.13%
• 10 years: 10.13%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

44% more call options, than puts

Call options by funds: $42.1M | Put options by funds: $29.1M

15% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 110

2.86% more ownership

Funds ownership: 60.75% [Q3] → 63.61% (+2.86%) [Q4]

3% more capital invested

Capital invested by funds: $7.34B [Q3] → $7.53B (+$187M) [Q4]

0% less funds holding

Funds holding: 920 [Q3] → 916 (-4) [Q4]

18% less funds holding in top 10

Funds holding in top 10: 11 [Q3] → 9 (-2) [Q4]

50% less repeat investments, than reductions

Existing positions increased: 198 | Existing positions reduced: 393

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $71 7% downside
• Avg. target: $80 4% upside
• High target: $85 12% upside

6 analyst ratings

• positive: 0 0%
• neutral: 5 83%
• negative: 1 17%

Morgan Stanley Patrick Wood 50% 1-year accuracy 6 / 12 met price target	5% upside $80	Equal-Weight Maintained	5 Mar 2025
Mizuho Steven Valiquette 29% 1-year accuracy 2 / 7 met price target	8% upside $82	Neutral Maintained	3 Mar 2025
Goldman Sachs David Roman 30% 1-year accuracy 6 / 20 met price target	7% downside $71	Sell Maintained	3 Mar 2025
Wells Fargo Vik Chopra 36% 1-year accuracy 4 / 11 met price target	1% downside $75	Equal-Weight Maintained	28 Feb 2025
Piper Sandler Jason Bednar 32% 1-year accuracy 12 / 37 met price target	10% upside $84	Neutral Maintained	28 Feb 2025